85 related articles for article (PubMed ID: 2161513)
1. B19 chronic bone marrow failure: a persistent parvovirus infection of humans.
Morinet F; Perol Y
Nouv Rev Fr Hematol (1978); 1990; 32(1):91-4. PubMed ID: 2161513
[TBL] [Abstract][Full Text] [Related]
2. Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy.
Isobe Y; Sugimoto K; Shiraki Y; Nishitani M; Koike K; Oshimi K
Am J Hematol; 2004 Dec; 77(4):370-3. PubMed ID: 15558805
[TBL] [Abstract][Full Text] [Related]
3. Haematological consequences of parvovirus B19 infection.
Brown KE
Baillieres Best Pract Res Clin Haematol; 2000 Jun; 13(2):245-59. PubMed ID: 10942624
[TBL] [Abstract][Full Text] [Related]
4. Immune response to B19 parvovirus and an antibody defect in persistent viral infection.
Kurtzman GJ; Cohen BJ; Field AM; Oseas R; Blaese RM; Young NS
J Clin Invest; 1989 Oct; 84(4):1114-23. PubMed ID: 2551923
[TBL] [Abstract][Full Text] [Related]
5. Erythroid hypoplasia due to chronic infection with parvovirus B19.
Belloy M; Morinet F; Blondin G; Courouce AM; Peyrol Y; Vilmer E
N Engl J Med; 1990 Mar; 322(9):633-4. PubMed ID: 2154693
[No Abstract] [Full Text] [Related]
6. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
[TBL] [Abstract][Full Text] [Related]
7. [Congenital aplastic anemia caused by parvovirus B19 infection].
Vepreková L; Jelínek J; Zeman J
Cas Lek Cesk; 2001 Mar; 140(6):178-80. PubMed ID: 11347208
[TBL] [Abstract][Full Text] [Related]
8. [Persistent parvovirus B19 infection in a patient with AIDS].
García-Tapia AM; Fernández C; Bascuñana A
Enferm Infecc Microbiol Clin; 1993 Feb; 11(2):107-8. PubMed ID: 8386943
[No Abstract] [Full Text] [Related]
9. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.
Lehmann HW; Knöll A; Küster RM; Modrow S
Arthritis Rheum; 2003 Jun; 48(6):1631-8. PubMed ID: 12794831
[TBL] [Abstract][Full Text] [Related]
10. Possible evolution of human parvovirus B19 infection into erythroleukemia.
Sitar G; Balduini CL; Manenti L; Castello A; Balanzin D; Ascari E
Haematologica; 1999 Oct; 84(10):957-9. PubMed ID: 10509050
[No Abstract] [Full Text] [Related]
11. Evidence for persistence of human parvovirus B19 DNA in bone marrow.
Cassinotti P; Burtonboy G; Fopp M; Siegl G
J Med Virol; 1997 Nov; 53(3):229-32. PubMed ID: 9365887
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis of parvovirus B19 infection in hematological patients with partial red cell aplasia of the bone marrow].
Iaguzhinskaia OE; Pivnik AV; Fevraleva IS; Sudarikov AB; Lisovina IuS; Loginova IV; Shitareva IV
Ter Arkh; 2001; 73(8):50-6. PubMed ID: 11599268
[TBL] [Abstract][Full Text] [Related]
13. [Research on Parvovirus B19 infections and chronic articular manifestations in a Tunisian hospital].
Regaya F; Khelifa R; Zouari R; Kchir M; Karoui M; Essid R
Arch Inst Pasteur Tunis; 2003; 80(1-4):9-15. PubMed ID: 15941063
[TBL] [Abstract][Full Text] [Related]
14. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
[TBL] [Abstract][Full Text] [Related]
15. Establishment of functional B cell memory against parvovirus B19 capsid proteins may be associated with resolution of persistent infection.
Corcoran A; Crowley B; Dewhurst C; Pizer BL; Doyle S
J Med Virol; 2006 Jan; 78(1):125-8. PubMed ID: 16299723
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of antibodies to human parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection.
Jones LP; Erdman DD; Anderson LJ
J Infect Dis; 1999 Aug; 180(2):500-4. PubMed ID: 10395869
[TBL] [Abstract][Full Text] [Related]
17. Chronic human parvovirus B19 infection associated with interstitial lung disease.
Klar A; Halamish A; Shoseyov D; Cassinotti P; Siegl G; Springer C; Shazberg G; Hurvitz H
Isr Med Assoc J; 2002 Oct; 4(10):825-6. PubMed ID: 12389353
[No Abstract] [Full Text] [Related]
18. [Human parvovirus B19 infection mimicking systemic lupus erythematosus: case report].
Banno S; Matsumoto Y; Sugiura Y; Ueda R
Ryumachi; 1997 Aug; 37(4):581-6. PubMed ID: 9311285
[TBL] [Abstract][Full Text] [Related]
19. Dose-by-dose virological and hematological responses to intravenous immunoglobulin in an immunocompromised patient with persistent parvovirus B19 infection.
Tang JW; Lau JS; Wong SY; Cheung JL; Chan CH; Wong KF; Wong A; Chan PK
J Med Virol; 2007 Sep; 79(9):1401-5. PubMed ID: 17607784
[TBL] [Abstract][Full Text] [Related]
20. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection.
Hsu TC; Chen TY; Lin MC; Tzang BS; Tsay GJ
J Gastroenterol Hepatol; 2005 May; 20(5):733-8. PubMed ID: 15853987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
